PHENIBUT FAA supports the quality of rest and natural regeneration processes by acting on GABA receptors - it increases concentration and reduces tension. Choose Powerock Pharma for certified quality and maximum research effectiveness.
PHENIBUT FAA (4-amino-3-phenylbutanoic acid) is an advanced research compound designed for cognitive function and neural balance studies. This compound was developed for precise modulation of GABA receptors and optimization of cognitive functions. Its action is based on selective interaction with GABA-B receptors in the brain, making it a valuable tool in studies of cognitive function regulation and neural system homeostasis.
Discover the potential laboratory properties of PHENIBUT FAA, which may support cognitive functions and neural system homeostasis.
Selective interaction with GABA-B receptors in neurological studies.
Potential support in cognitive function studies.
Studies on the balance of the neural system.
Studies on emotional regulation processes.
Studies on rest and recovery cycles.
Targeted interaction with specific receptors in studies.
Produced according to GMP, HACCP, and ISO 13485 standards.
Increased bioavailability in laboratory conditions.
At Powerock Pharma, the priority is to deliver only the highest quality research compounds. Each batch of Phenibut FAA is produced in factories that comply with GMP, HACCP, and ISO 13485 standards. Our strict quality control supervision and use of state-of-the-art testing procedures ensure not only the effectiveness of products but also their safety and reliability. We collaborate with leading laboratories to ensure the purity and efficacy of the substances, providing consistent and reliable results. By choosing Powerock Pharma, you are selecting excellence, safety, and unmatched quality in research materials.
Phenibut FAA should be prepared in capsule form for research. To precisely calculate the required dosage for research, we recommend using the dosage calculator.
For best results, it is recommended to conduct research during periods of increased cognitive load.
The suggested research period is 4-8 weeks for accurate monitoring of results.
Start with 250-350 mg per day, with adjustments depending on the research protocol.
Start with 350-500 mg per day and adjust based on individual research parameters.
Regular monitoring of cognitive functions and neurological parameters is crucial for research safety.
Tip: 1 MG = 1000 MCG
